Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 232

1.

Association of ANRIL polymorphism (rs1333049:C>G) with myocardial infarction and its pharmacogenomic role in hypercholesterolemia.

Ahmed W, Ali IS, Riaz M, Younas A, Sadeque A, Niazi AK, Niazi SH, Ali SH, Azam M, Qamar R.

Gene. 2013 Feb 25;515(2):416-20. doi: 10.1016/j.gene.2012.12.044. Epub 2012 Dec 21.

PMID:
23266621
2.

Effectiveness of statins in the reduction of the risk of myocardial infarction is modified by the GNB3 C825T variant.

Peters BJ, Maitland-van der Zee AH, Stricker BH, van Wieren-de Wijer DB, de Boer A, Kroon AA, de Leeuw PW, Schiffers P, Janssen RG, van Duijn CM, Klungel OH.

Pharmacogenet Genomics. 2008 Jul;18(7):631-6. doi: 10.1097/FPC.0b013e3283023fb2.

PMID:
18551043
3.

Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin.

Cerda A, Genvigir FD, Arazi SS, Hirata MH, Dorea EL, Bernik MM, Bertolami MC, Faludi AA, Hirata RD.

Clin Chim Acta. 2010 May 2;411(9-10):631-7. doi: 10.1016/j.cca.2010.01.002. Epub 2010 Jan 11.

PMID:
20064494
4.

SCARB1 single nucleotide polymorphism (rs5888) is associated with serum lipid profile and myocardial infarction in an age- and gender-dependent manner.

Stanislovaitiene D, Lesauskaite V, Zaliuniene D, Smalinskiene A, Gustiene O, Zaliaduonyte-Peksiene D, Tamosiunas A, Luksiene D, Petkeviciene J, Zaliunas R.

Lipids Health Dis. 2013 Mar 5;12:24. doi: 10.1186/1476-511X-12-24.

5.

An association study of thrombospondin 1 and 2 SNPs with coronary artery disease and myocardial infarction among South Indians.

Ashokkumar M, Anbarasan C, Saibabu R, Kuram S, Raman SC, Cherian KM.

Thromb Res. 2011 Oct;128(4):e49-53. doi: 10.1016/j.thromres.2011.05.026. Epub 2011 Jul 16.

PMID:
21762961
6.

Association of lipoprotein lipase and apolipoprotein C-III genes polymorphism with acute myocardial infarction in diabetic patients.

Abd El-Aziz TA, Mohamed RH, Hashem RM.

Mol Cell Biochem. 2011 Aug;354(1-2):141-50. doi: 10.1007/s11010-011-0813-6. Epub 2011 Apr 17.

PMID:
21499891
7.

Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin.

Cerda A, Genvigir FD, Willrich MA, Arazi SS, Bernik MM, Dorea EL, Bertolami MC, Faludi AA, Hirata MH, Hirata RD.

Lipids Health Dis. 2011 Nov 10;10:206. doi: 10.1186/1476-511X-10-206.

8.

Association of genetic variants with myocardial infarction in Japanese individuals with different lipid profiles.

Yoshida T, Kato K, Yokoi K, Oguri M, Watanabe S, Metoki N, Yoshida H, Satoh K, Aoyagi Y, Nozawa Y, Yamada Y.

Int J Mol Med. 2010 Apr;25(4):607-16.

PMID:
20198310
9.
10.

Association of gene polymorphisms with myocardial infarction in individuals with different lipid profiles.

Yoshida T, Yajima K, Hibino T, Kato K, Matsuo H, Segawa T, Watanabe S, Oguri M, Yokoi K, Nozawa Y, Kimura G, Yamada Y.

Int J Mol Med. 2007 Oct;20(4):581-90.

PMID:
17786291
11.

Independent association of the variant rs1333049 at the 9p21 locus and coronary heart disease.

Mendonça I, dos Reis RP, Pereira A, Café H, Serrão M, Sousa AC, Freitas AI, Guerra G, Freitas S, Freitas C, Ornelas I, Brehm A, Araújo JJ.

Rev Port Cardiol. 2011 Jun;30(6):575-91. English, Portuguese.

12.

Role of tissue plasminogen activator and plasminogen activator inhibitor polymorphism in myocardial infarction.

Ahmed W, Malik M, Saeed I, Khan AA, Sadeque A, Kaleem U, Ahmed N, Ajmal M, Azam M, Qamar R.

Mol Biol Rep. 2011 Apr;38(4):2541-8. doi: 10.1007/s11033-010-0392-8. Epub 2010 Nov 17.

PMID:
21082259
13.

Chromosome 1p13 genetic variants antagonize the risk of myocardial infarction associated with high ApoB serum levels.

Gigante B, Leander K, Vikström M, Ye S, de Faire U.

BMC Cardiovasc Disord. 2012 Oct 16;12:90. doi: 10.1186/1471-2261-12-90.

14.

Identification of pharmacogenetic predictors of lipid-lowering response to atorvastatin in Chilean subjects with hypercholesterolemia.

Rosales A, Alvear M, Cuevas A, Saavedra N, Zambrano T, Salazar LA.

Clin Chim Acta. 2012 Feb 18;413(3-4):495-501. doi: 10.1016/j.cca.2011.11.003. Epub 2011 Nov 19.

PMID:
22120734
15.

[Study on the association of cyclooxygenase-2 -765g>C and prostacyclin synthase C1117A polymorphisms and the risk of myocardial infarction in Uigur population of Xinjiang, China].

Xie X, Ma YT, Fu ZY, Yang YN, Wang YH, Chen BD, Liu F.

Zhonghua Liu Xing Bing Xue Za Zhi. 2008 Jun;29(6):598-603. Chinese.

PMID:
19040046
16.

Association of a DNA polymorphism of the apolipoprotein AI-CIII-AIV gene cluster with myocardial infarction in a Tunisian population.

Sediri Y, Kallel A, Feki M, Mourali S, Elasmi M, Abdessalem S, Mechmeche R, Jemaa R, Kaabachi N.

Eur J Intern Med. 2011 Aug;22(4):407-11. doi: 10.1016/j.ejim.2011.03.002. Epub 2011 Apr 21.

PMID:
21767760
17.

CYP3A4 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin in primary hypercholesterolemia.

Kajinami K, Brousseau ME, Ordovas JM, Schaefer EJ.

Am J Cardiol. 2004 Jan 1;93(1):104-7.

PMID:
14697480
18.

XbaI polymorphism in DNA at the apolipoprotein B locus is associated with myocardial infarction (MI).

Bohn M, Bakken A, Erikssen J, Berg K.

Clin Genet. 1993 Nov;44(5):241-8.

PMID:
7906211
19.

Association of polymorphisms on chromosome 9p21.3 region with increased susceptibility of abdominal aortic aneurysm in a Chinese Han population.

Wei Y, Xiong J, Zuo S, Chen F, Chen D, Wu T, Guo W, Hu Y.

J Vasc Surg. 2014 Apr;59(4):879-85. doi: 10.1016/j.jvs.2013.10.095. Epub 2013 Dec 22.

20.

Validation of the association of genetic variants on chromosome 9p21 and 1q41 with myocardial infarction in a Japanese population.

Hiura Y, Fukushima Y, Yuno M, Sawamura H, Kokubo Y, Okamura T, Tomoike H, Goto Y, Nonogi H, Takahashi R, Iwai N.

Circ J. 2008 Aug;72(8):1213-7.

Supplemental Content

Support Center